Clinical Trial Shows Virgin Coconut Oil a Promising Supplement for Covid-19

The first of three clinical trials conducted by the Department of Science and Technology (DOST) on Virgin Coconut Oil (VCO) as supplement for the treatment of COVID-19 showed promise with majority of patients involved in the study sent home.

The fact that majority of the patients are now home is a good indication, DOST Secretary Fortunato dela Pena said, adding the protocol remains and patients will still be given VCO. The secretary said the study requires more participants to forge a better conclusion.  

Dela Pena said the initial study was conducted at the Sta. Rosa Community Hospital and it involved 45 patients with mild symptoms. They were given VCO after meals for 28 days.

The second trial with 50 patients will be held soon at the Philippine General Hospital (PGH).  The third trial will be in Singapore. The study aims to assess the possible benefits of VCO if given to patients with moderate to severe COVID-19 in addition to other drugs being assessed in the clinical trials.